FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.
Washington, DC (March 13, 2015) – FOCUS Investment Banking, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services announced today that Tectrol, Inc. has been acquired by CUI Global, Inc. (NASDAQ:CUI). FOCUS represented Tectrol in the transaction.
Washington, DC (January 7, 2014) FOCUS, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that its client, Medvance Ltd., has been acquired by NAMSA. FOCUS represented Medvance in the transaction, adding another international deal to its list of completed 2013 transactions.
Washington, DC (June 4, 2012) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that Pleiad, domiciled in Stirling,Scotland, with a substantial presence in the U.S. (Cambridge, Massachusetts) has been acquired by CROMSOURCE, headquartered in Verona, Italy. FOCUS represented Pleiad in the transaction.
Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC © 2024 FOCUS Investment Banking LLC
Securities transactions conducted by FOCUS Securities LLC, an affiliated company, registered broker-dealer and member FINRA/SIPC
Member of M&A Worldwide 
